Nuveen’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.4M | Sell |
88,511
-30,960
| -26% | -$4.45M | ﹤0.01% | 1470 |
|
|
2025
Q4 | $17M | Buy |
119,471
+6,917
| +6% | +$927K | ﹤0.01% | 1235 |
|
|
2025
Q3 | $13.5M | Buy |
112,554
+40,201
| +56% | +$5.09M | ﹤0.01% | 1381 |
|
|
2025
Q2 | $9.56M | Sell |
72,353
-5,620
| -7% | -$762K | ﹤0.01% | 1537 |
|
|
2025
Q1 | $10.8M | Sell |
77,973
-124
| -0.2% | -$19.2K | ﹤0.01% | 1506 |
|
|
2024
Q4 | $12.1M | Sell |
78,097
-8,867
| -10% | -$1.5M | ﹤0.01% | 1500 |
|
|
2024
Q3 | $15.8M | Sell |
86,964
-14,550
| -14% | -$2.15M | ﹤0.01% | 1328 |
|
|
2024
Q2 | $12.1M | Buy |
101,514
+56,695
| +126% | +$5.97M | ﹤0.01% | 1475 |
|
|
2024
Q1 | $4.81M | Sell |
44,819
-378
| -0.8% | -$37.6K | ﹤0.01% | 2012 |
|
|
2023
Q4 | $4.51M | Buy |
45,197
+247
| +0.5% | +$24.2K | ﹤0.01% | 2040 |
|
|
2023
Q3 | $5.35M | Sell |
44,950
-12,656
| -22% | -$1.89M | ﹤0.01% | 1829 |
|
|
2023
Q2 | $10.3M | Sell |
57,606
-1,290
| -2% | -$237K | ﹤0.01% | 1495 |
|
|
2023
Q1 | $9.71M | Buy |
58,896
+12,532
| +27% | +$2.16M | ﹤0.01% | 1500 |
|
|
2022
Q4 | $7.3M | Sell |
46,364
-1,208
| -3% | -$184K | ﹤0.01% | 1689 |
|
|
2022
Q3 | $7.16M | Buy |
47,572
+3,018
| +7% | +$502K | ﹤0.01% | 1687 |
|
|
2022
Q2 | $7.32M | Buy |
44,554
+2,181
| +5% | +$420K | ﹤0.01% | 1711 |
|
|
2022
Q1 | $10.5M | Buy |
42,373
+898
| +2% | +$201K | ﹤0.01% | 1617 |
|
|
2021
Q4 | $9.84M | Buy |
41,475
+3,610
| +10% | +$843K | ﹤0.01% | 1705 |
|
|
2021
Q3 | $8.84M | Sell |
37,865
-1,295
| -3% | -$272K | ﹤0.01% | 1868 |
|
|
2021
Q2 | $8.06M | Sell |
39,160
-7,736
| -16% | -$1.59M | ﹤0.01% | 1995 |
|
|
2021
Q1 | $9.63M | Sell |
46,896
-1,504
| -3% | -$318K | ﹤0.01% | 1824 |
|
|
2020
Q4 | $10.4M | Buy |
48,400
+6,554
| +16% | +$1.27M | ﹤0.01% | 1695 |
|
|
2020
Q3 | $7.65M | Sell |
41,846
-494
| -1% | -$93K | ﹤0.01% | 1677 |
|
|
2020
Q2 | $7.8M | Buy |
42,340
+1,305
| +3% | +$259K | ﹤0.01% | 1657 |
|
|
2020
Q1 | $8.28M | Buy |
41,035
+4,176
| +11% | +$804K | ﹤0.01% | 1413 |
|
|
2019
Q4 | $6.9M | Sell |
36,859
-4,529
| -11% | -$779K | ﹤0.01% | 1817 |
|
|
2019
Q3 | $6.61M | Sell |
41,388
-1,314
| -3% | -$262K | ﹤0.01% | 1807 |
|
|
2019
Q2 | $10.8M | Buy |
+42,702
| New | +$9.9M | ﹤0.01% | 1555 |
|
|
2013
Q3 | – | Sell |
-24,872
| Closed | -$1.79M | – | 1515 |
|
|
2013
Q2 | $1.79M | Buy |
+24,872
| New | +$1.64M | 0.01% | 796 |
|
Other funds holding ICUI
VPM
VCM
RRAM
Nuveen's ICUI Position: Q1 2026 in Review
Nuveen reduced its ICU Medical (ICUI) stake by 26% in Q1 2026, selling an estimated $4.45M and leaving 88,511 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1470.
Nuveen first reported a position in ICUI in Q2 2013 and has held it in 29 quarters since. The position peaked at $17M in Q4 2025. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- Nuveen held 88,511 shares of ICU Medical worth $11.4M as of Q1 2026.
- Nuveen sold 30,960 ICU Medical shares in Q1 2026, an estimated $4.45M.
- ICU Medical made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #1470 holding.
- Nuveen first reported a position in ICU Medical in Q2 2013 and has held it in 29 quarters since.
- Nuveen's ICU Medical position peaked at $17M in Q4 2025.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.